Keeping up with WCLC24 with Eric K. Singhi

The WCLC24 is taking place at the San Diego Convention Center from September 7 to 10, 2024.

The WCLC24 is organised by the International Association for the Study of Lung Cancer (IASLC). This major conference is gathering leading experts, researchers, and oncologists to present and discuss the latest advancements in lung cancer research, treatment, and personalized therapies, fostering collaborative efforts towards overcoming the challenges of lung cancer.

Eric K. Singhi, Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, shared some insights from the conference.

WCLC24 welcome by co-chairs

Our amazing co-chairs of WCLC24 welcome us in English, Portuguese, and Spanish to the faculty dinner!

Appreciate the hard work, detailed planning, and inclusivity!

Coming home from WCLC24 with more than just the science!

The FURTHER study

David Planchard presents the FURTHER study: Firmonertinib at two dose levels in TKI naive mNSCLC with EGFR PACC mutations.

-PACC mutations ~12.5% of all EGFR mutations, currently no broadly utilized SOC
-At 240 mg daily: ORR 63.6%
-Encouraging CNS activity
-AE: Higher dose with increased GI toxicity

Key updates for patients with HER2 positive NSCLC from the phase 1/2 SOHO-01 study

Our Xiuning Le presents a key update for patients with HER2 positive NSCLC from the phase 1/2 SOHO-01 study.

BAY 2927088
-Oral reversible TKI
-ORR 72% (90% in YMVA)
-mDOR 8.7 mos
-mPFS 7.5 mos
-AE: 25% grade 3+ diarrhea

Oncology Brothers Live event

Such a great group shot from the Oncology Brothers LIVE event last night!

Tina Cascone is the ultimate role model for ALL early-career thoracic oncologists.

Her compassionate care and dedication to integrating groundbreaking science are redefining standards.

Proud to call her my colleague at MD Anderson Cancer Centre.

A heart warming recognition for colleagues

Grateful to be surrounded by such incredible colleagues in thoracic oncology.

For more updates on WCLC24, visit oncodaily.com